Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
The report details the trend, potential and market size of Immunotherapy market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.
The first part (Chapter1-7) mainly covers the qualitative analysis of Immunotherapymarket, defines the market attractiveness level of Immunotherapy market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.
The second part (Chapter8-12), based on the segmentation of Immunotherapy industry, describes the types of Immunotherapy market, the applications of major players and the market size, and deeply analyzes the current situation of the global Immunotherapy market and the development prospects and opportunities of Immunotherapy industry.
The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.
As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Immunotherapy market in Chapter 13.
By Player:
Biogen
Novartis
Bristol-Myers Squibb
Amgen, Inc
Pfizer
Merck
Abbvie
Celgene
Johnson & Johnson
Roche
By Type:
Monoclonal Antibodies
Therapeutic Vaccines
Checkpoint Inhibitors
Non-Specific Immunotherapy
By End-User:
Sublingual Immunotherapy
Subcutaneous Immunotherapy
By Geography:
-
United States
-
Europe
-
China
-
Japan
-
India
-
South Korea
TABLE OF CONTENT
1 Introduction
-
1.1 Market Definition
-
1.2 Market Segment Analysis
-
1.3 Market Size 2022
-
1.4 Immunotherapy Market Outlook: Forecast for 2022 - 2028
-
1.5 Pricing Analysis
2 Executive Summary
3 Immunotherapy Market Lineage Outlook
-
3.1 Parent Market Outlook
-
3.2 Related/Ancillary Market Outlook
-
3.3 Penetration & Growth Prospect Mapping, 2022
4 Market Analysis Tools: Porter's Five Forces
-
4.1 Supplier Power
-
4.2 Buyer Power
-
4.3 Substitution Threat
-
4.4 Threat of New Entrants
-
4.5 Competitive Rivalry
5 Immunotherapy Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)
-
5.1 Political/Legal Landscape
-
5.2 Economic Landscape
-
5.3 Social Landscape
-
5.4 Technology Landscape
6 Immunotherapy Market - Value Chain Analysis
-
6.1 Industry's Value Chain Analysis
-
6.2 Product Life Cycle
-
6.3 User Perspective Analysis
7 Region and Country-wise Immunotherapy Market Analysis and Outlook to 2022
-
7.1 Global Immunotherapy Consumption (2017-2022)
-
7.2 United States Immunotherapy Consumption (2017-2022)
-
7.3 Europe Immunotherapy Consumption (2017-2022)
-
7.4 China Immunotherapy Consumption (2017-2022)
-
7.5 Japan Immunotherapy Consumption (2017-2022)
-
7.6 India Immunotherapy Consumption (2017-2022)
-
7.7 South Korea Immunotherapy Consumption (2017-2022)
8 Region and Country-wise Immunotherapy Market Analysis and Outlook to 2028
-
8.1 Global Immunotherapy Consumption Forecast (2022-2028)
-
8.2 United States Immunotherapy Consumption Forecast (2022-2028)
-
8.3 Europe Immunotherapy Consumption Forecast (2022-2028)
-
8.4 China Immunotherapy Consumption Forecast (2022-2028)
-
8.5 Japan Immunotherapy Consumption Forecast (2022-2028)
-
8.6 India Immunotherapy Consumption Forecast (2022-2028)
-
8.7 South Korea Immunotherapy Consumption Forecast (2022-2028)
9 Global Immunotherapy Market Outlook by Types and Applications to 2022
-
9.1 Global Immunotherapy Consumption and Growth Rate by Type (2017-2022)
-
9.1.1 Global Monoclonal Antibodies Consumption and Growth Rate (2017-2022)
-
9.1.2 Global Therapeutic Vaccines Consumption and Growth Rate (2017-2022)
-
9.1.3 Global Checkpoint Inhibitors Consumption and Growth Rate (2017-2022)
-
9.1.4 Global Non-Specific Immunotherapy Consumption and Growth Rate (2017-2022)
-
9.2 Global Immunotherapy Consumption and Growth Rate by Application (2017-2022)
-
9.2.1 Global Sublingual Immunotherapy Consumption and Growth Rate (2017-2022)
-
9.2.2 Global Subcutaneous Immunotherapy Consumption and Growth Rate (2017-2022)
10 Global Immunotherapy Market Outlook by Types and Applications to 2028
-
10.1 Global Immunotherapy Consumption Forecast and Growth Rate by Type (2022-2028)
-
10.1.1 Global Monoclonal Antibodies Consumption Forecast and Growth Rate (2022-2028)
-
10.1.2 Global Therapeutic Vaccines Consumption Forecast and Growth Rate (2022-2028)
-
10.1.3 Global Checkpoint Inhibitors Consumption Forecast and Growth Rate (2022-2028)
-
10.1.4 Global Non-Specific Immunotherapy Consumption Forecast and Growth Rate (2022-2028)
-
10.2 Global Immunotherapy Consumption Forecast and Growth Rate by Application (2022-2028)
-
10.2.1 Global Sublingual Immunotherapy Consumption Forecast and Growth Rate (2022-2028)
-
10.2.2 Global Subcutaneous Immunotherapy Consumption Forecast and Growth Rate (2022-2028)
11 Global Immunotherapy Import and Export Analysis (Top 5 Countries)
-
11.1 Global Immunotherapy Import by Region (Top 5 Countries) (2017-2028)
-
11.2 Global Immunotherapy Export by Region (Top 5 Countries) (2017-2028)
12 Coronavirus Disease (COVID-19) Impact
-
12.1 Industry Impact Analysis
-
12.2 Immunotherapy Market Outlook to 2028 - COVID-19 Affected Forecasts
13 Competition Matrix
-
13.1 Target Markets
-
13.2 Comprehensive Analysis of Products in Competitive Markets
14 Global Immunotherapy Market Competitive Analysis
-
14.1 Biogen
-
14.1.1 Biogen Company Details
-
14.1.2 Biogen Immunotherapy Sales, Price, Value and Gross Profit (2017-2022)
-
14.1.3 Biogen Immunotherapy Product and Service
-
14.2 Novartis
-
14.2.1 Novartis Company Details
-
14.2.2 Novartis Immunotherapy Sales, Price, Value and Gross Profit (2017-2022)
-
14.2.3 Novartis Immunotherapy Product and Service
-
14.3 Bristol-Myers Squibb
-
14.3.1 Bristol-Myers Squibb Company Details
-
14.3.2 Bristol-Myers Squibb Immunotherapy Sales, Price, Value and Gross Profit (2017-2022)
-
14.3.3 Bristol-Myers Squibb Immunotherapy Product and Service
-
14.4 Amgen, Inc
-
14.4.1 Amgen, Inc Company Details
-
14.4.2 Amgen, Inc Immunotherapy Sales, Price, Value and Gross Profit (2017-2022)
-
14.4.3 Amgen, Inc Immunotherapy Product and Service
-
14.5 Pfizer
-
14.5.1 Pfizer Company Details
-
14.5.2 Pfizer Immunotherapy Sales, Price, Value and Gross Profit (2017-2022)
-
14.5.3 Pfizer Immunotherapy Product and Service
-
14.6 Merck
-
14.6.1 Merck Company Details
-
14.6.2 Merck Immunotherapy Sales, Price, Value and Gross Profit (2017-2022)
-
14.6.3 Merck Immunotherapy Product and Service
-
14.7 Abbvie
-
14.7.1 Abbvie Company Details
-
14.7.2 Abbvie Immunotherapy Sales, Price, Value and Gross Profit (2017-2022)
-
14.7.3 Abbvie Immunotherapy Product and Service
-
14.8 Celgene
-
14.8.1 Celgene Company Details
-
14.8.2 Celgene Immunotherapy Sales, Price, Value and Gross Profit (2017-2022)
-
14.8.3 Celgene Immunotherapy Product and Service
-
14.9 Johnson & Johnson
-
14.9.1 Johnson & Johnson Company Details
-
14.9.2 Johnson & Johnson Immunotherapy Sales, Price, Value and Gross Profit (2017-2022)
-
14.9.3 Johnson & Johnson Immunotherapy Product and Service
-
14.10 Roche
-
14.10.1 Roche Company Details
-
14.10.2 Roche Immunotherapy Sales, Price, Value and Gross Profit (2017-2022)
-
14.10.3 Roche Immunotherapy Product and Service
15 Appendix
TABLE OF CHARTS
-
Table Definition of Immunotherapy
-
Figure Immunotherapy Picture
-
Table Global Immunotherapy Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Immunotherapy Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Immunotherapy Market: Year-over-year Growth 2022 - 2028 (%)
-
Table Parent Market Analysis
-
Figure Parent Market Price
-
Table Related/Ancillary Market Outlook Analysis
-
Table Supplier Power Analysis
-
Table Buyer Power Analysis
-
Table Substitution Threat Analysis
-
Table Threat of New Entrants Analysis
-
Table Competitive Rivalry Analysis
-
Figure Global Immunotherapy Consumption by Country (2017-2022)
-
Figure United States Immunotherapy Consumption and Growth Rate (2017-2022)
-
Table Europe Immunotherapy Consumption and Growth Rate (2017-2022)
-
Figure China Immunotherapy Consumption and Growth Rate (2017-2022)
-
Figure Japan Immunotherapy Consumption and Growth Rate (2017-2022)
-
Figure India Immunotherapy Consumption and Growth Rate (2017-2022)
-
Figure South Korea Immunotherapy Consumption and Growth Rate (2017-2022)
-
Figure Global Immunotherapy Consumption Forecast by Country (2022-2028)
-
Figure United States Immunotherapy Consumption Forecast and Growth Rate (2022-2028)
-
Table Europe Immunotherapy Consumption Forecast and Growth Rate (2022-2028)
-
Figure China Immunotherapy Consumption Forecast and Growth Rate (2022-2028)
-
Figure Japan Immunotherapy Consumption Forecast and Growth Rate (2022-2028)
-
Figure India Immunotherapy Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Korea Immunotherapy Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Monoclonal Antibodies Consumption and Growth Rate (2017-2022)
-
Figure Global Therapeutic Vaccines Consumption and Growth Rate (2017-2022)
-
Figure Global Checkpoint Inhibitors Consumption and Growth Rate (2017-2022)
-
Figure Global Non-Specific Immunotherapy Consumption and Growth Rate (2017-2022)
-
Figure Global Sublingual Immunotherapy Consumption and Growth Rate (2017-2022)
-
Figure Global Subcutaneous Immunotherapy Consumption and Growth Rate (2017-2022)
-
Figure Global Monoclonal Antibodies Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Therapeutic Vaccines Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Checkpoint Inhibitors Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Non-Specific Immunotherapy Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Sublingual Immunotherapy Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Subcutaneous Immunotherapy Consumption Forecast and Growth Rate (2022-2028)
-
Table Global Immunotherapy Import by Region (Top 5 Countries) (2017-2028)
-
Table Global Immunotherapy Export by Region (Top 5 Countries) (2017-2028)
-
Table Biogen (Foundation Year, Company Profile and etc.)
-
Table Biogen Immunotherapy Sales, Price, Value and Gross Profit (2017-2022)
-
Table Biogen Immunotherapy Product and Service
-
Table Novartis (Foundation Year, Company Profile and etc.)
-
Table Novartis Immunotherapy Sales, Price, Value and Gross Profit (2017-2022)
-
Table Novartis Immunotherapy Product and Service
-
Table Bristol-Myers Squibb (Foundation Year, Company Profile and etc.)
-
Table Bristol-Myers Squibb Immunotherapy Sales, Price, Value and Gross Profit (2017-2022)
-
Table Bristol-Myers Squibb Immunotherapy Product and Service
-
Table Amgen, Inc (Foundation Year, Company Profile and etc.)
-
Table Amgen, Inc Immunotherapy Sales, Price, Value and Gross Profit (2017-2022)
-
Table Amgen, Inc Immunotherapy Product and Service
-
Table Pfizer (Foundation Year, Company Profile and etc.)
-
Table Pfizer Immunotherapy Sales, Price, Value and Gross Profit (2017-2022)
-
Table Pfizer Immunotherapy Product and Service
-
Table Merck (Foundation Year, Company Profile and etc.)
-
Table Merck Immunotherapy Sales, Price, Value and Gross Profit (2017-2022)
-
Table Merck Immunotherapy Product and Service
-
Table Abbvie (Foundation Year, Company Profile and etc.)
-
Table Abbvie Immunotherapy Sales, Price, Value and Gross Profit (2017-2022)
-
Table Abbvie Immunotherapy Product and Service
-
Table Celgene (Foundation Year, Company Profile and etc.)
-
Table Celgene Immunotherapy Sales, Price, Value and Gross Profit (2017-2022)
-
Table Celgene Immunotherapy Product and Service
-
Table Johnson & Johnson (Foundation Year, Company Profile and etc.)
-
Table Johnson & Johnson Immunotherapy Sales, Price, Value and Gross Profit (2017-2022)
-
Table Johnson & Johnson Immunotherapy Product and Service
-
Table Roche (Foundation Year, Company Profile and etc.)
-
Table Roche Immunotherapy Sales, Price, Value and Gross Profit (2017-2022)
-
Table Roche Immunotherapy Product and Service
-
